Platensimycin is an experimental new drug being trialed in an effort to combat MRSA. Manufactured by a strain of Streptomyces platensis, it represents a previously unknown class of antibiotics, which acts by blocking enzymes involved in the synthesis of fatty acids, which bacteria need to construct cell membranes. Currently being researched by Merck.
This article is licensed under the GNU Free Documentation License.
It uses material from the
"Platensimycin".
Home Page • arts • business • computers • games • health • hospitals • home • kids & teens • news • physicians • recreation• reference • regional • science • shopping • society • sports • world